Lilly shares fall as obesity drug sales miss forecasts
Edwards data show benefit of early TAVR over ‘watchful waiting’
GSK tries to steady the ship as Arexvy sales plummet in wake of CDC guidance changes
AstraZeneca's China president faces 'ongoing investigation' by authorities in the country
*please scroll down for all the latest news*
